Glioquell
GlioQuell is an Imperial College biopharmaceutical spinout company dedicated to developing technologies and therapeutics targeting cellular bioenergetics. Based on cutting-edge proprietary science, the company is discovering and developing novel therapeutics for treating refractory brain tumours and other diseases with significant medical and societal burden. Our innovative strategy is designed for targeted modulation of cellular metabolism to affect the viability of specific cell types, including highly proliferative malignant glioma cells. Our founding directors and advisors include leaders in mitochondrial biology and clinical medicine, with decades of experience in discovery and translation of novel findings into the clinic.
7-day free trial · no credit card
Verified contacts
1
available on Kipplo
LinkedIn employees
2
1 to 10 range
Open roles
—
no listings
Distinct roles
1
indexed titles
Tech stack
0
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 1 verified contacts at Glioquell
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
1 contacts with verified email or phone · masked until revealed.
Showing 1 of 1 verified contacts
Top roles at Glioquell
1 distinct titles indexed · top 1 shown.
- 1co-founder
Sign up to unlock all 1 contacts at Glioquell
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 1 verified contacts at Glioquell
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.